In a crossover RCT of 21 healthy adults, 5 mg oral melatonin vs placebo worsened glucose tolerance (11.7%) and cut early C-peptide response (−19.2%) in MTNR1B risk-allele carriers (n=10) but not noncarriers, with first-phase β-cell responsivity suppressed by 40%.
RCTn = 21
Qian et al. Melatonin Impairs Glucose Tolerance, First-Phase Insulin Secretion, and Insulin Feedback Inhibition; Interaction With MTNR1B Diabetes Risk Variant